ClinicalTrials.Veeva

Menu

Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea (Rifaximin 600)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status and phase

Withdrawn
Phase 4

Conditions

Travelers' Diarrhea

Treatments

Drug: Rifaximin

Study type

Interventional

Funder types

Other

Identifiers

NCT00875875
Ericsson-001

Details and patient eligibility

About

The study will compare durations of diarrhea among subjects who report to clinic for treatment and who receive either:

  1. standard rifaximin therapy at a dose of 200 mg three times a day for 3 days, OR
  2. a single 600 mg dose of rifaximin daily for 3 days.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • passage of 3 or more unformed stools in 24 hours plus an additional symptom of enteric disease such as abdominal cramps, nausea, vomiting, or fever; and investigator verification that an unformed stool has been submitted.
  • is > 18 years of age
  • has diarrhea (at least three unformed stools in 24 hrs) plus at least one additional sign or symptom of enteric illness
  • has acute diarrhea less than 1 week's duration
  • willingness to provide a diarrhea stool sample
  • willingness to keep a daily diary for 5 days
  • signed informed consent

Exclusion criteria

  • fever or bloody diarrhea
  • has taken predictably effective antibiotics in the past week (e.g. quinolones, TMP/SMX, azalide or doxycycline)
  • is pregnant now, likely to become pregnant, or breast-feeding
  • has duration of diarrhea of greater than 1 weeks
  • is allergic to Rifampin or Rifaximin
  • has a history of significant underlying enteric, pulmonary, cardiac, renal disease, or any CNS disorder
  • is more than moderately dehydrated

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

1
Active Comparator group
Description:
This is the approved treatment regimen for travelers' diarrhea (600 mg)
Treatment:
Drug: Rifaximin
2
Active Comparator group
Description:
This is the same dose as the standard dose, given once daily (200 mg)
Treatment:
Drug: Rifaximin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems